Yiyang Wang

Ueruemqi, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Multi-Omics Characterization of ABHD12 Across Pan-Cancer and Validation of Its Role in Promoting Proliferation and Metastasis in Breast Cancer.

Multi-Omics Characterization of ABHD12 Across Pan-Cancer and Validation of Its Role in Promoting Proliferation and Metastasis in Breast Cancer.

Journal: Breast cancer (Dove Medical Press)
Published: February 11, 2026

Integrated pan cancer analysis with breast cancer validation identifies SEC13 homolog as prognostic biomarker and immunotherapy target.

Integrated pan cancer analysis with breast cancer validation identifies SEC13 homolog as prognostic biomarker and immunotherapy target.

Journal: Scientific reports
Published: February 06, 2026

Pan-cancer analysis and breast cancer validation reveal DEAD-box helicase 23 as a crucial prognostic and immuno-biomarker.

Pan-cancer analysis and breast cancer validation reveal DEAD-box helicase 23 as a crucial prognostic and immuno-biomarker.

Journal: Scientific reports
Published: January 07, 2026

The value of Protein Phosphatase Methylesterase 1 in diagnosis, prognosis and immunoregulation: from pan-cancer analysis to breast cancer verification.

The value of Protein Phosphatase Methylesterase 1 in diagnosis, prognosis and immunoregulation: from pan-cancer analysis to breast cancer verification.

Journal: Frontiers in immunology
Published: December 18, 2025

CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation.

CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation.

Journal: Frontiers in oncology
Published: July 21, 2025

CLIC6's role in cancer: from broad analysis to breast cancer validation.

CLIC6's role in cancer: from broad analysis to breast cancer validation.

Journal: Frontiers in oncology
Published: July 16, 2025

Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker.

Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker.

Journal: Breast cancer (Dove Medical Press)
Published: July 14, 2025

Bystin is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis to Validation in Breast Cancer.

Bystin is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis to Validation in Breast Cancer.

Journal: Breast cancer (Dove Medical Press)
Published: June 11, 2025

Factors influencing the efficacy of neoadjuvant chemotherapy for HER-2-low early-stage breast cancer and a predictive model for pathological complete response.

Factors influencing the efficacy of neoadjuvant chemotherapy for HER-2-low early-stage breast cancer and a predictive model for pathological complete response.

Journal: Gland surgery
Published: January 09, 2025

Diagnostics and immunological function of CENPN in human tumors: from pan-cancer analysis to validation in breast cancer.

Diagnostics and immunological function of CENPN in human tumors: from pan-cancer analysis to validation in breast cancer.

Journal: Translational cancer research
Published: September 25, 2024

Visualization analysis of breast cancer-related ubiquitination modifications over the past two decades.

Visualization analysis of breast cancer-related ubiquitination modifications over the past two decades.

Journal: Discover oncology
Published: September 11, 2024

Diagnostic value of 5 miRNAs combined detection for breast cancer.

Diagnostic value of 5 miRNAs combined detection for breast cancer.

Journal: Frontiers in genetics
Published: August 19, 2024
Showing 1-12 of 17

Last Updated: 09/26/2026